Tectonic Therapeutic (TECX) Tops Q2 EPS by 17c

Tectonic Therapeutic (NASDAQ: TECX) reported Q2 EPS of ($1.18), $0.17 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Tectonic Therapeutic (TECX) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Is Software back from the dead? Truist lists M&A candidates amid Workday rumors
• Applied Materials (AMAT) PT Raised to $700 at Bernstein SocGen Group